Profile of patients receiving intravitreal anti-vascular endothelial growth factor injections during COVID-19-related lockdown
Purpose: The aim of this study was to analyze the impact on vision due to delay in presentation of patients requiring intravitreal anti-vascular endothelial growth factor (anti-VEGF) injections, consequent to COVID-19-related travel restrictions. Methods: Data were collected retrospectively of patie...
Main Authors: | Manavi D Sindal, Kanika Chhabra, Vaibhav Khanna |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2021-01-01
|
Series: | Indian Journal of Ophthalmology |
Subjects: | |
Online Access: | http://www.ijo.in/article.asp?issn=0301-4738;year=2021;volume=69;issue=3;spage=730;epage=733;aulast=Sindal |
Similar Items
-
The Dilemma between the Randomized Control Trials and Real Life Practice in the Treatment of Retinal Diseases with Intravitreal anti-VEGF agents
by: Abdullah Özkaya, et al.
Published: (2017-05-01) -
Intravitreal bevacizumab injection in the treatment of macular edema secondary to branch retinal vein occlusion
by: Şeref İstek, et al.
Published: (2014-06-01) -
Clinical efficacy of intravitreous injection of Conbercept in the treatment of macular edema secondary to retinal branch vein occlusion
by: Hong-Liang Jia, et al.
Published: (2020-07-01) -
Intravitreal injection of Ranibizumab combined with retinal photocoagulation for CRVO with retinal neovascularization and macular edema
by: Yong Wang
Published: (2018-06-01) -
Study on the change of retinal thickness and choroidal thickness and correlative factors for macular edema after Ranibizumab injection
by: Guan-Lu Liang, et al.
Published: (2018-05-01)